Lakefront Biotherapeutics | GLPG - Creditori Commerciali





Creditori Commerciali Cambiamento Data
argenx SE USD 719M 164.73M 2026-06
AstraZeneca USD 23.57B 679M 2026-09
Biogen USD 430.3M 26.4M 2026-09
Genmab DKK 116M 110M 2026-06
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Incyte USD 235.37M 1.16B 2026-09
Merck EUR 2.07B 61M 2026-06
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 24.55B 957M 2026-09
UCB EUR 4.04B 755M 2025-12
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09